Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

Zhu, Feng-Cai ; Li, Yu-Hua ; Guan, Xu-Hua ; Hou, Li-Hua ; Wang, Wen-Juan ; Li, Jing-Xin ; Wu, Shi-Po ; Wang, Bu-Sen ; Wang, Zhao ; Wang, Lei ; Jia, Si-Yue ; Jiang, Hu-Dachuan ; Wang, Ling ; Jiang, Tao ; Hu, Yi ; Gou, Jin-Bo ; Xu, Sha-Bei ; Xu, Jun-Jie ; Wang, Xue-Wen ; Wang, Wei ; Chen, Wei

The Lancet (British edition), 2020-06, Vol.395 (10240), p.1845-1854 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível